We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » FDA Rejects Citizen’s Petition for Levaquin Labeling Changes
FDA Rejects Citizen’s Petition for Levaquin Labeling Changes
The FDA has denied a citizen’s petition from the Southern Network on Adverse Reactions (SONAR) to change the labeling on Johnson & Johnson’s antibiotic Levaquin (levofloxacin).